Company profile: Neuroplast
1.1 - Company Overview
Company description
- Provider of neuro-regenerative personalized medicine, a promising therapy that needs dedicated uniform standards and regulations.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Neuroplast
NuVision Biotherapies
HQ: United Kingdom
Website
- Description: Provider of high-quality, affordable biotherapies for treating front-of-the-eye disease and trauma. A biotechnology research and development spin-out from the University of Nottingham, incorporated in July 2014 to commercialise ophthalmic biotherapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NuVision Biotherapies company profile →
PolarityTE
HQ: United States
Website
- Description: Provider of SkinTE, an investigational product for complex chronic and acute wound treatment that uses a patient's own tissue to regenerate functional skin, and a clinical development program advancing SkinTE through clinical trials to obtain regulatory approval.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PolarityTE company profile →
Regentys
HQ: United States
Website
- Description: Provider of early-stage regenerative medicine and innovative medical devices for gastrointestinal applications, including ECMH (Extracellular Matrix Hydrogel), a porcine-derived extracellular matrix hydrogel designed to create an environment favorable for new tissue growth to replace diseased or damaged tissue in the gastrointestinal tract.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Regentys company profile →
Artelon
HQ: United States
Website
- Description: Provider of bio-textile solutions for kinematic reinforcement of tendon and ligament reconstruction, developing synthetic materials for tissue reconstruction and restoring stability and motion. Products include FLEXBAND biomaterial and systems (Twist, Solo, Multi, FIX), FLEXBAND Plus, FLEXPATCH, Dynamic Matrix Technology used in over 60,000 implantations, and educational programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Artelon company profile →
Triad Life Sciences
HQ: United States
Website
- Description: Provider of regenerative medicine technologies based on placental-derived extracellular matrix for managing acute, traumatic, hard-to-heal and surgical wounds and burns. Offers InnovaMatrix AC and PD wound devices, InnovaBurn for partial-thickness burns, and the proprietary TriCleanse decellularization process, plus InnovaMatrix Reimbursement services for insurance verification, coding/billing, and prior authorization support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Triad Life Sciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Neuroplast
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Neuroplast
2.2 - Growth funds investing in similar companies to Neuroplast
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Neuroplast
4.2 - Public trading comparable groups for Neuroplast
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →